Differential αv integrin-mediated Ras-ERK signaling during two pathways of angiogenesis

Journal of Cell Biology

Volumn 162, Issue 5, 2003, Pages 933-943

  Hood, John D ^a,b   Frausto, Ricardo ^a   Kiosses, William B ^a   Schwartz, Martin A ^a,c   Cheresh, David A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b TargeGen Inc   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

C Raf protein; FGF receptor; Integrin alphaV; MAP ERK kinase; VEGF receptor

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; C RAF PROTEIN; CD51 ANTIGEN; FOCAL ADHESION KINASE; INTEGRIN; MITOGEN ACTIVATED PROTEIN KINASE; P21 ACTIVATED KINASE; PAK PROTEIN; PROTEIN; RAF PROTEIN; RAS PROTEIN; RETROVIRUS VECTOR; SERINE; UNCLASSIFIED DRUG; VASCULOTROPIN; ALPHAVBETA5 INTEGRIN; FIBROBLAST GROWTH FACTOR 2; P21 ACTIVATED KINASE 1; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE KINASE; VASCULOTROPIN A; VITRONECTIN RECEPTOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; CELL SURVIVAL; CHICK EMBRYO; CONTROLLED STUDY; EMBRYO; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VIRAL GENE DELIVERY SYSTEM; ANIMAL; DRUG ANTAGONISM; METABOLISM; PHYSIOLOGY;

ANIMALIA; UNIDENTIFIED RETROVIRUS;

ANIMALS; CHICK EMBRYO; ENZYME ACTIVATION; FIBROBLAST GROWTH FACTOR 2; FOCAL ADHESION PROTEIN-TYROSINE KINASES; INTEGRIN ALPHAVBETA3; INTEGRINS; MITOGEN-ACTIVATED PROTEIN KINASES; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS C-RAF; RAS PROTEINS; RECEPTORS, VITRONECTIN; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 0042386426     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.200304105     Document Type: Article

References (56)

1. Alavi, A., J.D. Hood, R. Frausto, D.G. Stupack, and D.A. Cheresh. 2003. Role of Raf in vascular protection from distinct apoptotic stimuli. Science. 301:94-96.
2. Alon, T., I. Hemo, A. Itin, J. Pe'er, J. Stone, and E. Keshet. 1995. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat. Med. 1:1024-1028.
3. Aplin, A.E., A.K. Howe, and R.L. Juliano. 1999. Cell adhesion molecules, signal transduction and cell growth. Curr. Opin. Cell Biol. 11:737-744.
4. Barberis, L., K.K. Wary, G. Fiucci, F. Liu, E. Hirsch, M. Brancaccio, F. Altruda, G. Tarone, and F.G. Giancotti. 2000. Distinct roles of the adaptor protein She and focal adhesion kinase in integrin signaling to ERK. J. Biol. Chem. 275:36532-36540.
5. Benjamin, L.E., D. Golijanin, A. Itin, D. Pode, and E. Keshet. 1999. Selective ablation of immature vessels in established human tumors follows vascular endothelial growth factor withdrawal. J. Clin. Invest. 103:159-165.
6. Bos, J.L. 1989. ras oncogenes in human cancer: a review. Cancer Res. 49:4682-4689.
7. Brooks, P.C., R.A. Clark, and D.A. Cheresh. 1994a. Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science. 264:569-571.
8. Brooks, P.C., A.M. Montgomery, M. Rosenfeld, R.A. Reisfeld, T. Hu, G. Klier, and D.A. Cheresh. 1994b. Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell. 79:1157-1164.
9. Chaudhary, A., W.G. King, M.D. Mattaliano, J.A. Frost, B. Diaz, D.K. Morrison, M.H. Cobb, M.S. Marshall, and J.S. Brugge. 2000. Phosphatidylinositol 3-kinase regulates raf1 through Pak phosphorylation of serine 338. Curr. Biol. 10:551-554.
10. Chen, Q., T.H. Lin, C.J. Der, and R.L. Juliano. 1996. Integrin-mediated activation of MEK and mitogen-activated protein kinase is independent of Ras. J. Biol. Chem. 271:18122-18127. (published erratum appears in J. Biol. Chem. 1996. 271:22280)
11. Chong, H., H.G. Vikis, and K.L. Guan. 2003. Mechanisms of regulating the raf kinase family. Cell. Signal. 15:463-469.
12. Cobb, B.S., M.D. Schaller, T.H. Leu, and J.T. Parsons. 1994. Stable association of pp60src and pp59fyn with the focal adhesion-associated protein tyrosine kinase, pp125FAK. Mol. Cell. Biol, 14:147-155.
13. del Pozo, M.A., L.S. Price, N.B. Alderson, X.D. Ren, and M.A. Schwartz. 2000. Adhesion to the extracellular matrix regulates the coupling of the small GTPase Rac to its effector PAK. EMBO J. 19:2008-2014.
14. Drogen, F., S.M. O'Rourke, V.M. Stucke, M. Jaquenoud, A.M. Neiman, and M. Peter. 2000. Phosphorylation of the MEKK Stel lp by the PAK-like kinase Ste20p is required for MAP kinase signaling in vivo. Curr. Biol. 10:630-639.
15. Eliceiri, B.P., and D.A. Cheresh. 2000. Role ofalpha v integrins during angiogenesis. Cancer J. 6 Suppl 3:S245-S249.
16. Eliceiri, B.P., R. Klemke, S. Stromblad, and D.A. Cheresh. 1998. Integrin alphavbeta3 requirement for sustained mitogen-activated protein kinase activity during angiogenesis. J. Cell Biol. 140:1255-1263.
17. Eliceiri, B.P., R. Paul, P.L. Schwartzberg, J.D. Hood, J. Leng, and D.A. Cheresh. 1999. Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. Mol. Cell. 4:915-924.
18. Eliceiri, B.P., X.S. Puente, J.D. Hood, D.G. Stupack, D.D. Schlaepfer, X.Z. Huang, D. Sheppard, and D.A. Cheresh. 2002. Src-mediated coupling of focal adhesion kinase to integrin αvβ5 in vascular endothelial growth factor signaling. J. Cell Biol. 157:149-159.
19. Fabian, J.R., I.O. Daar, and D.K. Morrison. 1993. Critical tyrosine residues regulate the enzymatic and biological activity of raf-1 kinase. Mol. Cell. Biol. 13:7170-7179.
20. Feig, L.A., and G.M. Cooper. 1988. Relationship among guanine nucleotide exchange, GTP hydrolysis, and transforming potential of mutated ras proteins. Mol. Cell. Biol. 8:2472-2478.
21. Friedlander, M., P.C. Brooks, R.W. Shaffer, C.M. Kincaid, J.A. Varner, and D.A. Cheresh. 1995. Definition of two angiogenic pathways by distinct alpha v integrins. Science. 270:1500-1502.
22. Friedlander, M., C.L. Theesfeld, M. Sugita, M. Fruttiger, M.A. Thomas, S. Chang, and D.A. Cheresh. 1996. Involvement of integrins alpha V beta3 and alphav beta5 in ocular neovascular diseases. Proc. Natl. Acad. Sci. USA. 93:9764-9769.
23. Gautschi, P., M. Frater-Schroder, and P. Bohlen. 1986. Partial molecular characterization of endothelial cell mitogens from human brain: acidic and basic fibroblast growth factors. FEBS Lett. 204:203-207.
24. Giroux, S., M. Tremblay, D. Bernard, J.F. Cardin-Girard, S. Aubry, L. Larouche, S. Rousseau, J. Huot, J. Landry, L. Jeannotte, and J. Charron. 1999. Embryonic death of Mek1-deficient mice reveals a role for this kinase in angiogenesis in the labyrinthine region of the placenta. Curr. Biol. 9:369-372.
25. He, H., V.J. Venema, X. Gu, R.C. Venema, M.B. Marrero, and R.B. Caldwell. 1999. Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1/KDR activation pf c-Src. J. Biol. Chem. 274:25130-25135.
26. Hood, J., and H.J. Granger. 1998. Protein kinase G mediates vascular endothelial growth factor-induced raf-I activation and proliferation in human endothelial cells. J. Biol. Chem. 273:23504-23508.
27. Hood, J.D., M. Bednarski, R. Frausto, S. Guccione, R.A. Reisfeld, R. Xiang, and D.A. Cheresh. 2002. Tumor regression by targeted gene delivery to the neovasculature. Science. 296:2404-2407.
28. Hughes, S.H., J.J. Greenhouse, C.J. Petropoulos, and P. Sutrave. 1987. Adaptor plasmids simplify the insertion of foreign DNA into helper-independent retroviral vectors. J. Virol. 61:3004-3012.
29. Huser, M., J. Luckett, A. Chiloeches, K. Mercer, M. Iwobi, S. Giblett, X.M. Sun, J. Brown, R. Marais, and C. Pritchard. 2001. MEK kinase activity is not necessary for raf-1 function. EMBO J. 20:1940-1951.
30. Hynes, R.O. 2002. A reevaluation of integrins as regulators of angiogenesis. Nat. Med. 8:918-921.
31. King, A.J., H. Sun, B. Diaz, D. Barnard, W. Miao, S. Bagrodia, and M.S. Marshall. 1998. The protein kinase Pak3 positively regulates raf-1 activity through phosphorylation of serine 338. Nature. 396:180-183.
32. Kiosses, W.B., J. Hood, S. Yang, M.E. Gerritsen, D.A. Cheresh, N. Alderson, and M.A. Schwartz. 2002. A dominant-negative p65 PAK peptide inhibits angiogenesis. Circ. Res. 90:697-702.
33. Klemke, R.L., S. Cai, A.L. Giannini, P.J. Gallagher, P. de Lanerolle, and D.A. Cheresh. 1997. Regulation ofcell motility by mitogen-activated protein kinase. J. Cell Biol. 137:481-492.
34. Kolch, W. 2000. Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. Biochem. J. 351:289-305.
35. Kolch, W., G. Heidecker, P. Lloyd, and U.R. Rapp. 1991. Raf-1 protein kinase is required for growth of induced NIH/3T3 cells. Nature. 349:426-428.
36. Leevers, S.J., H.F. Paterson, and C.J. Marshall. 1994. Requirement for Ras in raf activation is overcome by targeting raf to the plasma membrane. Nature. 369:411-414.
37. Leung, D.W., G. Cachianes, W.J. Kuang, D.V. Goeddel, and N. Ferrara. 1989. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 246:1306-1309.
38. Lin, T.H., Q. Chen, A. Howe, and R.L. Juliano. 1997. Cell anchorage permits efficient signal transduction between ras and its downstream kinases. J. Biol. Chem. 272:8849-8852.
39. Renshaw, M.W., X.D. Ren, and M.A. Schwartz. 1997. Growth factor activation of MAP kinase requires cell adhesion. EMBO J. 16:5592-5599.
40. Renshaw, M.W., L.S. Price, and M.A. Schwartz. 1999. Focal adhesion kinase mediates the integrin signaling requirement for growth factor activation of MAP kinase. J. Cell Biol. 147:611-618.
41. Reynolds, L.E., L. Wyder, J.C. Lively, D. Taverna, S.D. Robinson, X. Huang, D. Sheppard, R.O. Hynes, and K.M. Hodivala-Dilke. 2002. Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins. 2002. Nat. Med. 8:27-34.
42. Schaller, M.D. 2001. Biochemical signals and biological responses elicited by the focal adhesion kinase. Biochim. Biophys. Acta. 1540:1-21.
43. Schlaepfer, D.D., S.K. Hanks, T. Hunter, and P. van der Geer. 1994. Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature. 372:786-791.
44. Schlaepfer, D.D., C.R. Hauck, and D.J. Sieg. 1999. Signaling through focal adhesion kinase. Prog. Biophys. Mol. Biol. 71:435-478.
45. Schlessinger, J. 2000. New roles for Src kinases in control of cell survival and angiogenesis. Cell. 100:293-296.
46. Senger, D.R., C.A. Perruzzi, J. Feder, and H.F. Dvorak. 1986. A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res. 46:5629-5632.
47. Senger, D.R., C.A. Peruzzi, M. Streit, V.E. Koteliansky, A.R. de Fougerolles, and M. Detmar. 2002. The α1β1 and α2β1 integrins provide critical support for vascular endothelial growth factor signaling, endothelial cell migration and tumor angiogenesis. Am. J. Pathol. 160:195-204.
48. Sieg, D.J., C.R, Hauck, D. Ilic, C.K. Klingbeil, E. Schaefer, C.H. Damsky, and D.D. Schlaepfer. 2000. FAK integrates growth-factor and integrin signals to promote cell migration. Nat. Cell. Biol. 2:249-256.
49. Stokoe, D., S.G. Macdonald, K. Cadwallader, M. Symons, and J.F. Hancock. 1994. Activation of raf as a result of recruitment to the plasma membrane. Science. 264:1463-1467.
50. Stromblad, S., A. Fotedar, H. Brickner, C. Theesfeld, E. Aguilar de Diaz, M. Friedlander, and D.A. Cheresh. 2002. Loss of p53 compensates for αv-integrin function in retinal neovascularization. J. Biol. Chem. 277:13371-13374.
51. Stupack, D.G., X.S. Puente, S. Boutsaboualoy, C.M. Storgard, and D.A. Cheresh. 2001. Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins. J. Cell Biol. 155:459-470.
52. Taylor, S.J., and D. Shalloway. 1996. Cell cycle-dependent activation of Ras. Curr. Biol. 6:1621-1627.
53. Yip-Schneider, M.T., W. Miao, A. Lin, D.S. Barnard, G. Tzivion, and M.S. Marshall. 2000. Regulation of the raf-1 kinase domain by phosphorylation and 14-3-3 association. Biochem. J. 351:151-159.
54. Zang, M., C. Hayne, and Z. Luo. 2002. Interaction between active PAK1 and raf-1 is necessary for phosphorylation and activation of raf-1. J. Biol. Chem. 277:4395-4405.
55. Zenke, F.T., C.C. King, B.P. Bohl, and G.M. Bokoch. 1999. Identification of a central phosphorylation site in p21-activated kinase regulating autoinhibition and kinase activity. J. Biol. Chem. 274:32565-32573.
56. Zhao, Z.S., E. Manser, X.Q. Chen, C. Chong, T. Leung, and L. Lim. 1998. A conserved negative regulatory region in alphaPAK: inhibition ofPAK kinases reveals their morphological roles downstream of Cdc42 and Rac1. Mol. Cell. Biol. 18:2153-2163.